Leading Financial Service Provider in India | Canara Bank Securities Ltd

Aristo Bio-Tech and Lifescience Ltd.

May 02, 03:41 NSE 132.00(+ 0.00 0.00%)

Volume0

Prev. Close
132.00

Open Price
0.00

Today's Low / High

0.00 0.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

62.90 164.00

Market Cap. ( ₹ in Cr. )	89.86	P/BV	2.67	Book Value ( ₹ )	49.37
52 Week High/Low ( ₹ )	164/63	FV/ML	10/1600	P/E(X)	23.07
Book Closure	15/09/2023	EPS ( ₹ )	5.72	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Sep 24	Mar 24	Sep 23	Mar 23	Sep 22
Net Sales/Income from operations	214.15	112.32	132.83	88.81	129.05
Total Income From Operations	214.15	112.32	132.83	88.81	129.05

EXPENDITURE
Consumption of Raw Materials	197.02	102.50	120.58	79.53	118.74
Purchase of Traded Goods	0.00	0.00	0.00	0.03	0.93
Increase/Decrease in Stocks	0.35	1.33	1.32	-0.67	-2.79
Employees Cost	1.93	0.10	3.56	2.61	3.15
Depreciation	1.29	0.80	0.78	0.82	0.72
Other Expenses	6.71	5.15	2.12	3.67	3.96
Total Expenses	207.28	109.87	128.36	85.99	124.70

P/L Before Other Inc. , Int., Excpt. Items & Tax	6.86	2.45	4.47	2.82	4.35
Other Income	0.23	0.05	0.13	0.30	0.03
P/L Before Interest, Excpt. Items & Tax	7.09	2.50	4.60	3.12	4.37
Interest	1.02	0.68	1.02	1.98	0.77
P/L Before Exceptional Items & Tax	6.07	1.82	3.58	1.14	3.60
P/L Before Tax	6.07	1.82	3.58	1.14	3.60
Tax	1.52	0.50	1.01	0.14	1.03
P/L After Tax from Ordinary Activities	4.55	1.32	2.57	1.00	2.57
Net Profit/Loss For the Period	4.55	1.32	2.57	1.00	2.57

Equity Share Capital	6.81	6.81	6.81	6.81	5.00
Reserves And Surplus	31.35	26.80	25.75	23.35	12.44
EPS Before Extra Ordinary *
Basic EPS (Rs.)	6.69	1.94	3.78	1.78	3.77
Diluted EPS (Rs.)	6.69	1.94	3.78	1.78	3.77
EPS After Extra Ordinary *
Basic EPS (Rs.)	6.69	1.94	3.78	1.78	3.77
Diluted EPS (Rs.)	6.69	0.00	3.78	1.78	3.77

PBITOE Margin (%)	3.20	2.18	3.36	3.17	3.36
PBTE Margin (%)	2.83	1.62	2.69	1.28	2.78
PBT Margin (%)	2.83	1.62	2.69	1.28	2.78
PAT Margin (%)	2.12	1.17	1.93	1.12	1.98

Markets

Board Of Directors

HALF YEARLY RESULTS

Aristo Bio-Tech and Lifescience Ltd.